Schwarzinicines A−G (1−7), representing the first examples of 1,4-diarylbutanoid−phenethylamine conjugates, were isolated from the leaves of Ficus schwarzii. The structures of these compounds were determined by detailed analysis of their MS, 1D and 2D NMR data. Compounds 1−4 exhibited pronounced vasorelaxant effects in the rat isolated aorta (E max 106−120%; EC 50 0.96−2.10 μM). However, compounds 1 and 2 showed no cytotoxic effects against A549, MCF-7, and HCT 116 human cancer cells (IC 50 > 10 μM).T he genus Ficus, belonging to the Ficeae tribe of the family Moraceae, comprises more than 750 species distributed in the tropical and subtropical regions of the world, with about 100 of the species occurring in Malaysia. 1 A number of Ficus species were reported to possess multiple ethnomedicinal uses including for the treatment of diarrhea, dysentery, skin diseases, diabetes, inflammation, ulcers, and cancer-related diseases. 2 To date, only eight Ficus species have been reported for their alkaloidal content, namely, F. hispida, 3−6 F. f istulosa, 7−9 F. f istulosa var. tengerensis, 10 F. septica, 11−14 F. nota, 15 F. hirta, 16 F. pachyrhachis, 17 and F. pantoniana, 18 suggesting that plants of this genus are still largely underinvestigated. This prompted us to explore Ficus species that occur in Peninsular Malaysia for alkaloids that possess interesting structures and/or useful biological activities. In addition to our previous investigations into the alkaloidal contents of F. hispida, 3 F. f istulosa, 7 and F. fistulosa var. tengerensis, 10 we also investigated Ficus schwarzii Koord., a tree that can grow up to 15 m in height and is widely distributed in southern Myanmar, Thailand, Peninsular Malaysia, Sumatra, and Borneo. 19 Herein, we report the isolation and structure elucidation of seven new 1,4-diarylbutanoid−phenethylamine conjugates, namely, schwarzinicines A−G (1−7) (Figure 1), from the leaves of F. schwarzii. The vasorelaxant effects of schwarzinicines A−D (1−4) in rat isolated aorta and cytotoxic effects of schwarzinicines A and B (1 and 4) against three human cancer cell lines are also reported.